TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
16,928
|
15,726
|
13,775 |
| Financial expenses |
86
|
82
|
38 |
| Earnings before taxes |
552
|
1,051
|
838 |
| EBITDA |
673
|
1,169
|
885 |
| Total assets |
8,929
|
8,183
|
8,234 |
| Current assets |
6,258
|
5,401
|
5,710 |
| Current liabilities |
3,582
|
2,552
|
4,281 |
| Equity capital |
3,996
|
4,044
|
3,696 |
| - share capital |
100
|
104
|
103 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.8%
|
49.4%
|
44.9% |
| Turnover per employee |
1,058
|
1,123
|
918 |
| Profit as a percentage of turnover |
3.3%
|
6.7%
|
6.1% |
| Return on assets (ROA) |
7.1%
|
13.8%
|
10.6% |
| Current ratio |
174.7%
|
211.6%
|
133.4% |
| Return on equity (ROE) |
13.8%
|
26.0%
|
22.7% |
| Change turnover |
1,736
|
1,911
|
-2,630 |
| Change turnover % |
11%
|
14%
|
-16% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.